Adventris Pharmaceuticals
PrivateLast Round
Seed
Oct 18, 2024
Total Funding Raised
$12.5M
Company Overview
Adventris Pharmaceuticals operates in Healthcare & Life Sciences and is based in Baltimore, Maryland. Its latest recorded funding round was a Seed round in October 2024.
Adventris Pharmaceuticals is a biotechnology company that develops cancer vaccines designed to train the immune system to recognize and attack cancer-causing mutations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adventris Pharmaceuticals Comparables
Compare Adventris Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Elicio Therapeutics | 81% | |
| Circio Holding ASA | 78% | |
| Scancell Holdings Plc | 70% |
For institutional investors. Book with your work email.
Adventris Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 18, 2024 | ||||
| Pre Seed | Oct 2, 2023 |
For institutional investors. Book with your work email.
Adventris Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Refactor Capital | Pre Seed |
| Johns Hopkins Technology Ventures | Pre Seed |
| Johns Hopkins Technology Ventures | Pre Seed |
| Y Combinator | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 2, 2023
$500K round with Refactor Capital and Y Combinator.
For institutional investors. Book with your work email.
Adventris Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Adventris Pharmaceuticals's valuation, stock price, and market status.
Is Adventris Pharmaceuticals a public or private company?
Adventris Pharmaceuticals is a private company.
What is the current stock price of Adventris Pharmaceuticals?
Adventris Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Adventris Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Adventris Pharmaceuticals worth (valuation)?
Valuation information for Adventris Pharmaceuticals is not publicly available.
Can I buy Adventris Pharmaceuticals stock?
Adventris Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Adventris Pharmaceuticals's last funding round?
Adventris Pharmaceuticals's most recent funding round was Seed on October 18, 2024.
Who are the main investors in Adventris Pharmaceuticals?
Key investors in Adventris Pharmaceuticals include Refactor Capital, Johns Hopkins Technology Ventures, Johns Hopkins Technology Ventures, Y Combinator.
Will Adventris Pharmaceuticals IPO soon?
No public IPO plans have been announced for Adventris Pharmaceuticals.
How can I track Adventris Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Adventris Pharmaceuticals's shares on secondary markets.